University of Edinburgh spin-out developing the msX magnetic bead platform for preparing blood samples and capturing cell-free DNA to simplify and speed liquid biopsy workflows. Launched msX research kits in the US to serve cancer detection and genomic research.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| £1.58 M | Mar, 2026 | seed |
Industries
Frequently Asked Questions
Where is BIOCAPTIVA located?
BIOCAPTIVA is located in Edinburgh, United Kingdom.
What industries does BIOCAPTIVA operate in?
BIOCAPTIVA operates in the following industries: biotechnology, diagnostics, life sciences.
How much total funding has BIOCAPTIVA raised?
BIOCAPTIVA has raised a total of $1,580,000.
Who are the investors in BIOCAPTIVA?
The investors in BIOCAPTIVA are: Old College Capital, BBI, Scottish Enterprise, EverQuest Capital Partners, Archangels.
What technology has BIOCAPTIVA developed for liquid biopsies?
BIOCAPTIVA developed the BioCaptis, a medical device that captures significantly higher levels of cell-free DNA from the blood than traditional methods, enhancing the accuracy of cancer testing.
What are the main advantages of BIOCAPTIVA technology?
The technology provides a much larger sample of genetic material, which helps in detecting cancer earlier, monitoring disease progression more effectively, and reducing the likelihood of inconclusive test results.
Is BIOCAPTIVA based in a specific geographical location?
BIOCAPTIVA is a biotechnology company based in Edinburgh, Scotland, originating as a spin-out from the University of Edinburgh.
How does the BIOCAPTIVA device integrate with existing clinical workflows?
The BioCaptis device is designed to be used in clinical settings where patients are already receiving treatment or monitoring, providing a seamless way to collect high volumes of cfDNA during routine visits.
What specific types of genetic material does BIOCAPTIVA target?
The technology is specifically designed to capture cell-free DNA, including circulating tumor DNA, which is essential for identifying genetic mutations associated with various types of cancer.
What is the significance of the BIOCAPTIVA BioCaptis system for personalized medicine?
By providing a more comprehensive profile of a patient's cancer genetics, BIOCAPTIVA enables doctors to tailor treatments more precisely to the specific characteristics of an individual's tumor.